504 related articles for article (PubMed ID: 19940168)
1. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.
Lee B; London ED; Poldrack RA; Farahi J; Nacca A; Monterosso JR; Mumford JA; Bokarius AV; Dahlbom M; Mukherjee J; Bilder RM; Brody AL; Mandelkern MA
J Neurosci; 2009 Nov; 29(47):14734-40. PubMed ID: 19940168
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in striatal dopamine release in healthy adults.
Munro CA; McCaul ME; Wong DF; Oswald LM; Zhou Y; Brasic J; Kuwabara H; Kumar A; Alexander M; Ye W; Wand GS
Biol Psychiatry; 2006 May; 59(10):966-74. PubMed ID: 16616726
[TBL] [Abstract][Full Text] [Related]
3. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
[TBL] [Abstract][Full Text] [Related]
4. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
[TBL] [Abstract][Full Text] [Related]
6. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
[TBL] [Abstract][Full Text] [Related]
7. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
Ballard ME; Dean AC; Mandelkern MA; London ED
PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223
[TBL] [Abstract][Full Text] [Related]
8. Limbic striatal dopamine D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after exclusion of potential dissimulators.
Reeves SJ; Polling C; Stokes PR; Lappin JM; Shotbolt PP; Mehta MA; Howes OD; Egerton A
Psychiatry Res; 2012 Apr; 202(1):60-4. PubMed ID: 22595510
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D(2/3) receptor availability and human cognitive impulsivity: a high-resolution positron emission tomography imaging study with [¹¹C]raclopride.
Kim JH; Son YD; Kim HK; Lee SY; Kim YB; Cho ZH
Acta Neuropsychiatr; 2014 Feb; 26(1):35-42. PubMed ID: 25142098
[TBL] [Abstract][Full Text] [Related]
10. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
[TBL] [Abstract][Full Text] [Related]
11. Dissociable rate-dependent effects of oral methylphenidate on impulsivity and D2/3 receptor availability in the striatum.
Caprioli D; Jupp B; Hong YT; Sawiak SJ; Ferrari V; Wharton L; Williamson DJ; McNabb C; Berry D; Aigbirhio FI; Robbins TW; Fryer TD; Dalley JW
J Neurosci; 2015 Mar; 35(9):3747-55. PubMed ID: 25740505
[TBL] [Abstract][Full Text] [Related]
12. Relationship between impulsivity, prefrontal anticipatory activation, and striatal dopamine release during rewarded task performance.
Weiland BJ; Heitzeg MM; Zald D; Cummiford C; Love T; Zucker RA; Zubieta JK
Psychiatry Res; 2014 Sep; 223(3):244-52. PubMed ID: 24969539
[TBL] [Abstract][Full Text] [Related]
13. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
Landvogt C; Buchholz HG; Bernedo V; Schreckenberger M; Werhahn KJ
Epilepsia; 2010 Sep; 51(9):1699-706. PubMed ID: 20384765
[TBL] [Abstract][Full Text] [Related]
14. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
[TBL] [Abstract][Full Text] [Related]
15. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED
Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310
[TBL] [Abstract][Full Text] [Related]
16. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement.
Dalley JW; Fryer TD; Brichard L; Robinson ES; Theobald DE; Lääne K; Peña Y; Murphy ER; Shah Y; Probst K; Abakumova I; Aigbirhio FI; Richards HK; Hong Y; Baron JC; Everitt BJ; Robbins TW
Science; 2007 Mar; 315(5816):1267-70. PubMed ID: 17332411
[TBL] [Abstract][Full Text] [Related]
17. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D
Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974
[TBL] [Abstract][Full Text] [Related]
18. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
Melega WP; Lacan G; Desalles AA; Phelps ME
Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
[TBL] [Abstract][Full Text] [Related]
19. Decreased dopamine activity predicts relapse in methamphetamine abusers.
Wang GJ; Smith L; Volkow ND; Telang F; Logan J; Tomasi D; Wong CT; Hoffman W; Jayne M; Alia-Klein N; Thanos P; Fowler JS
Mol Psychiatry; 2012 Sep; 17(9):918-25. PubMed ID: 21747399
[TBL] [Abstract][Full Text] [Related]
20. Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users.
Tong J; Ross BM; Schmunk GA; Peretti FJ; Kalasinsky KS; Furukawa Y; Ang LC; Aiken SS; Wickham DJ; Kish SJ
Am J Psychiatry; 2003 May; 160(5):896-903. PubMed ID: 12727693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
